0
2023
Gene Expression Market

Gene Expression Market

by Products (Consumable, Instruments), by Application (Drug Discovery, Diagnostics), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A03809
Feb 2023 | Pages: 427
Tables: 131
Charts: 72
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Gene Expression Market Research, 2031

The global gene expression market size was valued at $8,505.71 million in 2021, and is projected to reach $17,960.77 million by 2031, growing at a CAGR of 7.7% from 2022 to 2031. Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product, such as a protein or an RNA molecule. These products are often essential for the cell to function normally. During gene expression, the DNA sequence of a gene is copied into a complementary RNA sequence, which can then be used to direct the synthesis of the corresponding protein or RNA molecule. Gene expression comprises transcription and translation processes. Transcription (DNA to RNA) refers to production of RNA copies of DNA with the help of the enzyme RNA polymerase. While translation (RNA to protein) is a process that results in the synthesis of proteins based on the information on the coding genes (messenger RNA). There is a possibility of the alteration of several steps in gene expression process such as in RNA splicing, post-translational modification of proteins and others.

The gene expression market decreased during the lockdown period owing to decrease in the number of research and development activities that have been severely affected due to lockdowns and travel restrictions, resulting in a slowdown in the introduction of new products and technologies.

Gene Expression Market

Historical overview 

The gene expression market size was analyzed qualitatively and quantitatively from 2018-2020. Most of the growth during this period was derived from Asia-Pacific owing to the rise in the prevalence of genetic diseases, geriatric population, chronic and acute diseases, as well as the rising awareness for personalized medicine and well-established presence of key pharmaceutical and biotechnology companies in the region.  

Market dynamics 

The increase in the prevalence of genetic disorder, growing awareness for personalized medicine, and an increasing application of gene expression in drug discovery are the major factors driving the growth of gene expression market share. For instance, according to the report published by the Centers for Disease Control and Prevention, in December 2022 it has been estimated that chromosomal defect affected 531 babies with trisomy 13 (Patau syndrome) which is 1 in every 7,409 births, 1,187 babies were affected by trisomy 18 (Edwards syndrome), and 5,568 babies acquired trisomy 21 (Down syndrome) in U.S. Thus, the increasing incidences of rare genetic and chromosomal disorders are anticipated to increase the demand for gene expression therapy, thereby driving the growth of the market. Moreover, the increase in the number of R&D activities and significant investments by the government to improve healthcare infrastructure have become vital tools for the growth of the market. The development of technologically advanced solutions is anticipated to provide gene expression market growth. For instance, in May 2020, 10x Genomics, Inc. launched 10x-targeted single-cell RNA sequencing, the company’s targeted gene expression solution for spatial genomics and single-cell analysis. This product can efficiently analyze a subset of genes of interest. Therefore, it reduces the computational & sequencing burden, streamlines data analysis, and increases sample throughput. In addition, rise in gene expression studies to analyze the COVID-19-risk variants are expected to drive the global market.


However, the high cost of instruments for gene expression and lack of skilled professional hampers the market growth. Conversely, increased investments in R&D for the development of new technologies for tissue-specific or cell-specific gene expression analysis, as well as increase in the prevalence of chronic and genetic disease may open up the new market potential for gene expression and are expected to provide a lucrative opportunity for the growth of the market during the forecast period.

Segmental Overview 

The gene expression market share is segmented on the basis of product, application, end-user, and region. As per product, the market is segmented into consumables and instruments. The instruments are further bifurcated into polymerase chain reaction, next generation sequencing, DNA microarrays and others. According to application, it is bifurcated into drug discovery and diagnostics. By end user, it is segmented into, pharmaceutical & biotechnology companies, academic & research institutes, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.  

By Product

The market is segmented into consumables and instruments. The consumables segment accounted for the largest share of the market. The dominance of this segment can be attributed to the increasing volume of genetic tests in drug discovery, biomarker discovery, and pharmacogenomics applications which are driving the growth of the consumer market. 

Gene Expression Market

By Application

The market is segmented into drug discovery and diagnostics. The diagnostics segment accounted for the largest share of the market. The dominance of this segment can be attributed to the increasing use of gene expression analysis for early and precise diagnosis of rare genetic disorders and chronic illnesses are the major factor that propel the growth of the market. 

Gene Expression Market

By End User

The market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. The pharmaceutical and biotechnology companies segment exhibited the highest growth in 2021, and is anticipated to lead during the forecast period, owing to the fact that pharmaceutical & biotechnology companies utilized gene expression analysis products & services to achieve the clinical research goals, such as drug discovery and development. Whereas, biopharmaceutical companies focus on developing targeted therapies, especially for the treatment of cancer, complex diseases, and rare genetic disorders which are the key factors that are expected to drive the growth of the market in upcoming years.   

Gene Expression Market

By Region

The gene expression market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the gene expression market in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major key players and the rising advancement in technology in this region drive the growth of the market. Moreover, the rising investment in latest gene expression technology and increasing research and development activities toward the development of gene therapy, especially in the U.S. propel the growth of the market. In addition, the increasing focus on gene expression studies, government initiatives, and the availability of funding for next-generation sequencing (NGS) research are driving the growth of the market in North America. 

Asia-Pacific is expected to grow at the fastest rate during the gene expression market forecast. The market growth in the Asia-Pacific region is supplemented by highly populated countries along with increasing collaboration between key organizations to improve quality of healthcare and research infrastructure, availability of government funding for research activities, and growing application of gene expression profiling owing to increasing focus on personalized medicine which are some of the key factors expected to propel the growth of the market in the region.    

Gene Expression Market

COMPETITION ANALYSIS 

The report provides competitive analysis and profiles of the major players in the gene expression industry, such as Illumina Inc., Agilent Technologies, Thermo Fisher Scientific Inc., PerkinElmer Inc., Oxford Nanopore Technologies, QIAGEN, Bio-Rad Laboratories Inc., PacBio, Promega Corporation, and  F. Hoffmann-La Roche Ltd.  Major players have adopted product launch, product expansion, and acquisition as key developmental strategies to improve the product portfolio of the gene expression market. 

Some examples of product developments in the market

Illumina, Inc. launched NovaSeq X Series (NovaSeq X and NovaSeq X Plus) new production-scale sequencers to accelerate genomic medicine. This revolutionary new technology can generate more than 20,000 whole genomes per year – 2.5 times the throughput of prior sequencers. Thus, launch of the NovaSeq X Series will help the company to gain a strong foothold in the gene expression industry market.

QIAGEN announced the expansion of its next-generation sequencing (NGS) portfolio with the launch of QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit, both of which set new standards in preparing samples for determining their nucleic acid sequences. 

PacBio announced the launch of its Multiplexed Arrays Sequencing (MAS-Seq) kit in partnership with the Broad Institute of MIT and Harvard and 10x Genomics, Inc. The kit is a first-of-its-kind kitted solution leveraging 10x Genomics’ Single Cell Gene Expression technology to enable cost-effective long-read single-cell RNA sequencing for a more complete interrogation of the transcriptome. 

Illumina Inc. announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise. 

Illumina, Inc. acquired BlueBee, a cloud-based software company, to accelerate processing, analysis and sharing of next generation sequencing data by the genomics analysis solutions provided by BlueBee for research and clinical customers.  

Thermo Fisher Scientific and Qatar Genome Program (QGP) had entered into a partnership with the goal of accelerating genomic research and clinical applications of predictive genomics in Qatar as a step toward expanding the benefits of precision medicine across Arab populations globally. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the gene expression market analysis from 2021 to 2031 to identify the prevailing gene expression market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the gene expression market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global gene expression market trends, key players, market segments, application areas, and market growth strategies.

Gene Expression Market Report Highlights

Aspects Details
Market Size By 2031 USD 18 billion
Growth Rate CAGR of 7.7%
Forecast period 2021 - 2031
Report Pages 427
By End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others
By Products
  • Consumable
  • Instruments
    • Type
      • Polymerase Chain Reaction
      • Next Generation Sequencing
      • DNA Microarrays
      • Others
By Application
  • Drug Discovery
  • Diagnostics
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players PacBio, Promega Corporation, F. Hoffmann-La Roche Ltd., QIAGEN, Agilent Technologies Inc., Oxford Nanopore Technologies, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Illumina Inc.
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Bargaining power of suppliers

      • 3.3.2. Bargaining power of buyers

      • 3.3.3. Threat of substitutes

      • 3.3.4. Threat of new entrants

      • 3.3.5. Intensity of rivalry

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in the prevalence of genetic disorders.
        • 3.4.1.2. Growing application of gene expression in drug discovery
        • 3.4.1.3. Rise in the demand of personalized medicine for genetic disorders

      • 3.4.2. Restraints

        • 3.4.2.1. High cost of gene expression instruments & reagents
        • 3.4.2.2. Lack of skilled professionals

      • 3.4.3. Opportunities

        • 3.4.3.1. High growth potential in developing economies

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: GENE EXPRESSION MARKET, BY PRODUCTS

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Consumable

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Instruments

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

      • 4.3.4. Instruments Gene Expression Market by Type

  • CHAPTER 5: GENE EXPRESSION MARKET, BY APPLICATION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Drug Discovery

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Diagnostics

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

  • CHAPTER 6: GENE EXPRESSION MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Pharmaceutical and Biotechnology Companies

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Academic and Research Institutes

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Others

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

  • CHAPTER 7: GENE EXPRESSION MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Products

      • 7.2.3. Market size and forecast, by Application

      • 7.2.4. Market size and forecast, by End User

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Products
          • 7.2.5.1.3. Market size and forecast, by Application
          • 7.2.5.1.4. Market size and forecast, by End User
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Products
          • 7.2.5.2.3. Market size and forecast, by Application
          • 7.2.5.2.4. Market size and forecast, by End User
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Products
          • 7.2.5.3.3. Market size and forecast, by Application
          • 7.2.5.3.4. Market size and forecast, by End User
    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Products

      • 7.3.3. Market size and forecast, by Application

      • 7.3.4. Market size and forecast, by End User

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Products
          • 7.3.5.1.3. Market size and forecast, by Application
          • 7.3.5.1.4. Market size and forecast, by End User
        • 7.3.5.2. France
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Products
          • 7.3.5.2.3. Market size and forecast, by Application
          • 7.3.5.2.4. Market size and forecast, by End User
        • 7.3.5.3. UK
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Products
          • 7.3.5.3.3. Market size and forecast, by Application
          • 7.3.5.3.4. Market size and forecast, by End User
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Products
          • 7.3.5.4.3. Market size and forecast, by Application
          • 7.3.5.4.4. Market size and forecast, by End User
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Products
          • 7.3.5.5.3. Market size and forecast, by Application
          • 7.3.5.5.4. Market size and forecast, by End User
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Products
          • 7.3.5.6.3. Market size and forecast, by Application
          • 7.3.5.6.4. Market size and forecast, by End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Products

      • 7.4.3. Market size and forecast, by Application

      • 7.4.4. Market size and forecast, by End User

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Products
          • 7.4.5.1.3. Market size and forecast, by Application
          • 7.4.5.1.4. Market size and forecast, by End User
        • 7.4.5.2. China
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Products
          • 7.4.5.2.3. Market size and forecast, by Application
          • 7.4.5.2.4. Market size and forecast, by End User
        • 7.4.5.3. Australia
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Products
          • 7.4.5.3.3. Market size and forecast, by Application
          • 7.4.5.3.4. Market size and forecast, by End User
        • 7.4.5.4. India
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Products
          • 7.4.5.4.3. Market size and forecast, by Application
          • 7.4.5.4.4. Market size and forecast, by End User
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Products
          • 7.4.5.5.3. Market size and forecast, by Application
          • 7.4.5.5.4. Market size and forecast, by End User
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Products
          • 7.4.5.6.3. Market size and forecast, by Application
          • 7.4.5.6.4. Market size and forecast, by End User
    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Products

      • 7.5.3. Market size and forecast, by Application

      • 7.5.4. Market size and forecast, by End User

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Products
          • 7.5.5.1.3. Market size and forecast, by Application
          • 7.5.5.1.4. Market size and forecast, by End User
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Products
          • 7.5.5.2.3. Market size and forecast, by Application
          • 7.5.5.2.4. Market size and forecast, by End User
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Products
          • 7.5.5.3.3. Market size and forecast, by Application
          • 7.5.5.3.4. Market size and forecast, by End User
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Products
          • 7.5.5.4.3. Market size and forecast, by Application
          • 7.5.5.4.4. Market size and forecast, by End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Illumina Inc.

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

      • 9.1.6. Business performance

      • 9.1.7. Key strategic moves and developments

    • 9.2. Agilent Technologies Inc.

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

      • 9.2.6. Business performance

    • 9.3. Thermo Fisher Scientific Inc.

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

      • 9.3.7. Key strategic moves and developments

    • 9.4. PerkinElmer Inc.

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

      • 9.4.7. Key strategic moves and developments

    • 9.5. Oxford Nanopore Technologies

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

      • 9.5.7. Key strategic moves and developments

    • 9.6. Promega Corporation

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

    • 9.7. PacBio

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

      • 9.7.6. Business performance

      • 9.7.7. Key strategic moves and developments

    • 9.8. Bio-Rad Laboratories, Inc.

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

      • 9.8.6. Business performance

    • 9.9. F. Hoffmann-La Roche Ltd.

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

      • 9.9.6. Business performance

    • 9.10. QIAGEN

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

      • 9.10.6. Business performance

      • 9.10.7. Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 01. GLOBAL GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 02. GENE EXPRESSION MARKET FOR CONSUMABLE, BY REGION, 2021-2031 ($MILLION)
    TABLE 03. GENE EXPRESSION MARKET FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
    TABLE 04. GLOBAL INSTRUMENTS GENE EXPRESSION MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 05. GLOBAL GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 06. GENE EXPRESSION MARKET FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
    TABLE 07. GENE EXPRESSION MARKET FOR DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
    TABLE 08. GLOBAL GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 09. GENE EXPRESSION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. GENE EXPRESSION MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
    TABLE 11. GENE EXPRESSION MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. GENE EXPRESSION MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 13. NORTH AMERICA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 14. NORTH AMERICA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 15. NORTH AMERICA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 16. NORTH AMERICA GENE EXPRESSION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 17. U.S. GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 18. U.S. GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 19. U.S. GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 20. CANADA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 21. CANADA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 22. CANADA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 23. MEXICO GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 24. MEXICO GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 25. MEXICO GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 26. EUROPE GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 27. EUROPE GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 28. EUROPE GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 29. EUROPE GENE EXPRESSION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 30. GERMANY GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 31. GERMANY GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 32. GERMANY GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 33. FRANCE GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 34. FRANCE GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 35. FRANCE GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 36. UK GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 37. UK GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 38. UK GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 39. ITALY GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 40. ITALY GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 41. ITALY GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 42. SPAIN GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 43. SPAIN GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 44. SPAIN GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 45. REST OF EUROPE GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 46. REST OF EUROPE GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 47. REST OF EUROPE GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 48. ASIA-PACIFIC GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 49. ASIA-PACIFIC GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 50. ASIA-PACIFIC GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 51. ASIA-PACIFIC GENE EXPRESSION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 52. JAPAN GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 53. JAPAN GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 54. JAPAN GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 55. CHINA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 56. CHINA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 57. CHINA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 58. AUSTRALIA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 59. AUSTRALIA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 60. AUSTRALIA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 61. INDIA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 62. INDIA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 63. INDIA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 64. SOUTH KOREA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 65. SOUTH KOREA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 66. SOUTH KOREA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 67. REST OF ASIA-PACIFIC GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 68. REST OF ASIA-PACIFIC GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 69. REST OF ASIA-PACIFIC GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 70. LAMEA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 71. LAMEA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 72. LAMEA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 73. LAMEA GENE EXPRESSION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 74. BRAZIL GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 75. BRAZIL GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 76. BRAZIL GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 77. SAUDI ARABIA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 78. SAUDI ARABIA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 79. SAUDI ARABIA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 80. SOUTH AFRICA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 81. SOUTH AFRICA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 82. SOUTH AFRICA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 83. REST OF LAMEA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
    TABLE 84. REST OF LAMEA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 85. REST OF LAMEA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 86. ILLUMINA INC.: KEY EXECUTIVES
    TABLE 87. ILLUMINA INC.: COMPANY SNAPSHOT
    TABLE 88. ILLUMINA INC.: PRODUCT SEGMENTS
    TABLE 89. ILLUMINA INC.: PRODUCT PORTFOLIO
    TABLE 90. ILLUMINA INC.: KEY STRATERGIES
    TABLE 91. AGILENT TECHNOLOGIES INC.: KEY EXECUTIVES
    TABLE 92. AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
    TABLE 93. AGILENT TECHNOLOGIES INC.: PRODUCT SEGMENTS
    TABLE 94. AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO
    TABLE 95. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
    TABLE 96. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
    TABLE 97. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
    TABLE 98. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
    TABLE 99. THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
    TABLE 100. PERKINELMER INC.: KEY EXECUTIVES
    TABLE 101. PERKINELMER INC.: COMPANY SNAPSHOT
    TABLE 102. PERKINELMER INC.: PRODUCT SEGMENTS
    TABLE 103. PERKINELMER INC.: PRODUCT PORTFOLIO
    TABLE 104. PERKINELMER INC.: KEY STRATERGIES
    TABLE 105. OXFORD NANOPORE TECHNOLOGIES: KEY EXECUTIVES
    TABLE 106. OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT
    TABLE 107. OXFORD NANOPORE TECHNOLOGIES: PRODUCT SEGMENTS
    TABLE 108. OXFORD NANOPORE TECHNOLOGIES: PRODUCT PORTFOLIO
    TABLE 109. OXFORD NANOPORE TECHNOLOGIES: KEY STRATERGIES
    TABLE 110. PROMEGA CORPORATION: KEY EXECUTIVES
    TABLE 111. PROMEGA CORPORATION: COMPANY SNAPSHOT
    TABLE 112. PROMEGA CORPORATION: PRODUCT SEGMENTS
    TABLE 113. PROMEGA CORPORATION: PRODUCT PORTFOLIO
    TABLE 114. PACBIO: KEY EXECUTIVES
    TABLE 115. PACBIO: COMPANY SNAPSHOT
    TABLE 116. PACBIO: PRODUCT SEGMENTS
    TABLE 117. PACBIO: PRODUCT PORTFOLIO
    TABLE 118. PACBIO: KEY STRATERGIES
    TABLE 119. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
    TABLE 120. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
    TABLE 121. BIO-RAD LABORATORIES, INC.: PRODUCT SEGMENTS
    TABLE 122. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
    TABLE 123. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
    TABLE 124. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
    TABLE 125. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
    TABLE 126. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
    TABLE 127. QIAGEN: KEY EXECUTIVES
    TABLE 128. QIAGEN: COMPANY SNAPSHOT
    TABLE 129. QIAGEN: PRODUCT SEGMENTS
    TABLE 130. QIAGEN: PRODUCT PORTFOLIO
    TABLE 131. QIAGEN: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 01. GENE EXPRESSION MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF GENE EXPRESSION MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN GENE EXPRESSION MARKET (2022-2031)
    FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
    FIGURE 05. LOW BARGAINING POWER OF BUYERS
    FIGURE 06. LOW THREAT OF SUBSTITUTES
    FIGURE 07. LOW THREAT OF NEW ENTRANTS
    FIGURE 08. LOW INTENSITY OF RIVALRY
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALGENE EXPRESSION MARKET
    FIGURE 10. GENE EXPRESSION MARKET, BY PRODUCTS, 2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF GENE EXPRESSION MARKET FOR CONSUMABLE, BY COUNTRY 2021-2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF GENE EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY 2021-2031(%)
    FIGURE 13. GENE EXPRESSION MARKET, BY APPLICATION, 2021(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF GENE EXPRESSION MARKET FOR DRUG DISCOVERY, BY COUNTRY 2021-2031(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF GENE EXPRESSION MARKET FOR DIAGNOSTICS, BY COUNTRY 2021-2031(%)
    FIGURE 16. GENE EXPRESSION MARKET, BY END USER, 2021(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GENE EXPRESSION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF GENE EXPRESSION MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2021-2031(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GENE EXPRESSION MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 20. GENE EXPRESSION MARKET BY REGION, 2021
    FIGURE 21. U.S. GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 22. CANADA GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 23. MEXICO GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 24. GERMANY GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 25. FRANCE GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 26. UK GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 27. ITALY GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 28. SPAIN GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 29. REST OF EUROPE GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 30. JAPAN GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 31. CHINA GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 32. AUSTRALIA GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 33. INDIA GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 34. SOUTH KOREA GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 35. REST OF ASIA-PACIFIC GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 36. BRAZIL GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 37. SAUDI ARABIA GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 38. SOUTH AFRICA GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 39. REST OF LAMEA GENE EXPRESSION MARKET, 2021-2031 ($MILLION)
    FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 44. COMPETITIVE DASHBOARD
    FIGURE 45. COMPETITIVE HEATMAP: GENE EXPRESSION MARKET
    FIGURE 46. TOP PLAYER POSITIONING, 2021
    FIGURE 47. ILLUMINA INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 48. ILLUMINA INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 49. ILLUMINA INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 50. AGILENT TECHNOLOGIES INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 51. AGILENT TECHNOLOGIES INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 52. AGILENT TECHNOLOGIES INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 53. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 54. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 55. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 56. PERKINELMER INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 57. PERKINELMER INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 58. PERKINELMER INC.: REVENUE SHARE BY REGION, 2019 (%)
    FIGURE 59. OXFORD NANOPORE TECHNOLOGIES: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 60. OXFORD NANOPORE TECHNOLOGIES: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 61. OXFORD NANOPORE TECHNOLOGIES: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 62. PACBIO: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 63. PACBIO: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 64. BIO-RAD LABORATORIES, INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 65. BIO-RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 66. BIO-RAD LABORATORIES, INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 67. F. HOFFMANN-LA ROCHE LTD.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 68. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 69. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 70. QIAGEN: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 71. QIAGEN: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 72. QIAGEN: REVENUE SHARE BY REGION, 2021 (%)

 
 

According to the insights of CXOs, increase in the prevalence of genetic disorders. is expected to offer profitable opportunities for the expansion of the market. In addition, growing application of gene expression in drug discovery, and rise in the demand of personalized medicine for genetic disorders boost the growth of the market.  

CXOs further added that the rise in genetic disorders and increase in public awareness, the demand for personalized medicine is surging which is expected to fuel the market growth. In addition, the surge in investments in R&D by pharmaceutical & biotechnology companies, the growing healthcare expenditure, and the increase in adoption of technologically advanced gene therapy are the key factors driving the growth of the market. However, the high cost of the instruments for gene expression, and lack of awareness of gene expression technology and its potential benefits hampers the growth of the market up to some extent over the forecast period.    

North America is expected to dominate the global gene expression market during the forecast period, followed by Europe. In addition, emerging economies such as India, China, Mexico, and Brazil are expected to offer lucrative opportunities owing to rapidly improving healthcare facilities and the rising number of genetic disorders and cancer cases which are the key factors attributed to the growth of the market.   

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Gene expression is an important life process through which gene sequences are transcribed into functional gene products such as functional RNAs or proteins. It plays an important role in functioning and development of an organism and provides a connection between gene-encoded information and a functional gene end-product. It is determined by deciphering the gene information during the transcription and translation process and is very useful in identifying the molecular signature of a disease and for determining biomarker in correlation with dose dependent cellular responses on exposure to drug or therapeutic candidate.

A. Increase in the prevalence of genetic disorders, growing application of gene expression in drug discovery and rise in the demand for personalized medicine for genetic disorders.

A. Diagnostic segment dominated the global market in 2021 and expected to continue this trend throughout the forecast period. The dominance of this segment can be attributed to the increasing use of gene expression analysis for early and precise diagnosis of rare genetic disorders and chronic illnesses which are the major factors that propel the growth of the market.

A. The total market value of the Gene Expression market is $8,505.71 million in 2021.

A. The market value of Gene Expression market in 2022 is $9220.19 million.

A. Top companies such as Illumina Inc., Agilent Technologies, Thermo Fisher Scientific Inc., PerkinElmer Inc., Oxford Nanopore Technologies, QIAGEN, Bio-Rad Laboratories Inc., PacBio, Promega Corporation, and F. Hoffmann-La Roche Ltd held a high market position in 2021.

A. High cost of gene expression instruments & reagents and lack of skilled professionals are the factors that hinders the growth of the market.

A. The gene expression market is segmented on the basis of product, application, and end-user. On the basis of product, the market is segmented into consumables and instruments.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Gene Expression Market

Start reading instantly.
This Report and over 67,070+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers